End-to-end solution in psychedelic therapies establishes Numinus as leader in emerging space Pharmaceutical Investing
Algernon Pharmaceuticals Announces Increase and Closing of CDN$1.55M Private Placement Pharmaceutical Investing
Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara Cannabis Investing News
FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech Cannabis Investing News
Revive Provides Update on its Clinical Development Plan for Cannabidiol in the Treatment of Autoimmune Hepatitis Life Science Investing
Industry Solutions from Lexaria’s DehydraTECH(TM) Hemp and Cannabis Powders Cannabis Investing News
